Terms: = Lung cancer AND NKX2-1, BCH, 7080, ENSG00000136352, P43699, TITF1, TEBP, BHC, NKX2A, TTF-1, NKX2_1, NK-2 AND Treatment
253 results:
1. Disease control in patients with non-small cell lung cancer using pemetrexed: Investigating the best treatment strategy.
Takahara Y; Abe R; Sumito N; Tanaka T; Ishige Y; Shionoya I; Yamamura K; Nishiki K; Nojiri M; Kato R; Shinomiya S; Oikawa T
Thorac Cancer; 2024 Apr; 15(12):987-993. PubMed ID: 38485287
[TBL] [Abstract] [Full Text] [Related]
2. Efficacy of immune checkpoint inhibitors in SMARCA4-deficient and TP53 mutant undifferentiated lung cancer.
Chen J; Zheng Q; Wang J; Zhang X; Lv Y
Medicine (Baltimore); 2024 Feb; 103(8):e36959. PubMed ID: 38394494
[TBL] [Abstract] [Full Text] [Related]
3. Synchronous double primary small cell lung cancer and invasive ductal breast carcinoma: a case report.
Gan J; Liu M; Liu F; Wen J; Fu W; Jia J
BMC Pulm Med; 2024 Feb; 24(1):93. PubMed ID: 38388422
[TBL] [Abstract] [Full Text] [Related]
4. "All in one" nanoprobe Au-ttf-1 for target FL/CT bioimaging, machine learning technology and imaging-guided photothermal therapy against lung adenocarcinoma.
Yang Z; Zhang Y; Tang L; Yang X; Song L; Shen C; Zvyagin AV; Li Y; Yang B; Lin Q
J Nanobiotechnology; 2024 Jan; 22(1):22. PubMed ID: 38184620
[TBL] [Abstract] [Full Text] [Related]
5. Different effects of crizotinib treatment in two non-small cell lung cancer patients with SDC4::ROS1 fusion variants.
Ohishi Y; Nakanishi Y; Hirotani Y; Suzuki A; Tanino T; Nishimaki-Watanabe H; Kobayashi H; Nozaki F; Ohni S; Tang X; Hayashi K; Nakagawa Y; Shimizu T; Tsujino I; Takahashi N; Gon Y; Masuda S
Thorac Cancer; 2024 Jan; 15(1):89-93. PubMed ID: 38093515
[TBL] [Abstract] [Full Text] [Related]
6. USP13 drives lung squamous cell carcinoma by switching lung club cell lineage plasticity.
Kwon J; Zhang J; Mok B; Allsup S; Kim C; Toretsky J; Han C
Mol Cancer; 2023 Dec; 22(1):204. PubMed ID: 38093367
[TBL] [Abstract] [Full Text] [Related]
7. Non-small Cell lung cancer Epigenomes Exhibit Altered DNA Methylation in Smokers and Never-smokers.
Karlow JA; Pehrsson EC; Xing X; Watson M; Devarakonda S; Govindan R; Wang T
Genomics Proteomics Bioinformatics; 2023 Oct; 21(5):991-1013. PubMed ID: 37742993
[TBL] [Abstract] [Full Text] [Related]
8. Clinicopathological features and differential diagnosis of gastric metastases.
Chen W; Liu C; Liu Y; Yuan J; Wang Z
World J Surg Oncol; 2023 Aug; 21(1):258. PubMed ID: 37608278
[TBL] [Abstract] [Full Text] [Related]
9. lung cancer with breast metastasis: a case report and review of the literature.
Cao X; Chen P; Agyekum EA; Zhang Q; Qian X; Wu T; Chambers KH; Yin L
J Int Med Res; 2023 Jul; 51(7):3000605231188287. PubMed ID: 37523488
[TBL] [Abstract] [Full Text] [Related]
10. A case report of pulmonary hepatoid adenocarcinoma: promoting standardized diagnosis and treatment of the rare disease.
Xu K; Gao J; Feng L; Fang Y; Tang X
Front Immunol; 2023; 14():1203876. PubMed ID: 37292208
[TBL] [Abstract] [Full Text] [Related]
11. Diffuse intrapulmonary mesothelioma mimicking pulmonary lepidic adenocarcinoma: a rare case report and review of the literature.
RanYue W; ChunYan W; Likun H; LiPing Z; JieLu L; ZhengWei D
Diagn Pathol; 2023 May; 18(1):64. PubMed ID: 37194050
[TBL] [Abstract] [Full Text] [Related]
12. Rationale and Design of the Phase II ANTELOPE Study of Atezolizumab, Carboplatin and nab-Paclitaxel vs. Pembrolizumab, Platinum and Pemetrexed in ttf-1 Negative, Metastatic lung Adenocarcinoma (AIO-TRK-0122).
Frost N; Bleckmann A; Griesinger F; Grohé C; Janning M; Kollmeier J; Reinmuth N; Sebastian M; Thomas M; Reck M
Clin Lung Cancer; 2023 Sep; 24(6):568-572. PubMed ID: 37169628
[TBL] [Abstract] [Full Text] [Related]
13. Metastases to the kidney from primary lung cancer : clinicopathological analysis of six cases in a single center.
Lian H; Pan X; Hong B; Min J; Huang F
Diagn Pathol; 2023 May; 18(1):60. PubMed ID: 37161448
[TBL] [Abstract] [Full Text] [Related]
14. Primary Ewing sarcoma of the lung: A systematic review of the recent literature.
Fedeli MA; Marras V; Fara AM; Deiana A; Lobrano R; Cossu A; Paliogiannis P
Ann Diagn Pathol; 2023 Aug; 65():152152. PubMed ID: 37149954
[TBL] [Abstract] [Full Text] [Related]
15. [ttf-1-negative lung adenocarcinoma: special features of systemic treatment].
Frost N; Reck M
Pneumologie; 2023 Jul; 77(7):426-429. PubMed ID: 37094793
[TBL] [Abstract] [Full Text] [Related]
16. Papillary thyroid carcinoma with desmoid-type fibromatosis: the clinicopathological features with characteristic imaging and molecular correlation requiring comprehensive treatment.
Huang H; Li L; Liu X; Zhao L; Cui Z; Zhang R; Chen S
Hum Pathol; 2023 Jun; 136():84-95. PubMed ID: 37019411
[TBL] [Abstract] [Full Text] [Related]
17. Molecular characteristics of lung adenocarcinoma with respect to patient age at diagnosis.
Staaf J; Aine M; Nacer DF; Planck M; Arbajian E
Int J Cancer; 2023 Jul; 153(1):197-209. PubMed ID: 36965051
[TBL] [Abstract] [Full Text] [Related]
18. Chemical fingerprints and implicated cancer risks of Polycyclic aromatic hydrocarbons (PAHs) from fine particulate matter deposited in human lungs.
Zhang X; Leng S; Qiu M; Ding Y; Zhao L; Ma N; Sun Y; Zheng Z; Wang S; Li Y; Guo X
Environ Int; 2023 Mar; 173():107845. PubMed ID: 36871324
[TBL] [Abstract] [Full Text] [Related]
19. [Duodenal bleeding due to metastasis from lung adenocarcinoma controlled by radiotherapy: A case report and literature review].
Severin S; Terrones Munoz V; Meert N; Peche R
Rev Mal Respir; 2023 Apr; 40(4):359-365. PubMed ID: 36868976
[TBL] [Abstract] [Full Text] [Related]
20. Identification of THSD7B and PRMT9 mutations as risk factors for familial lung adenocarcinoma: A case report.
Zhang Q; Zhao Y; Song Z; Zhang Q; Tian C; Li R; Zheng J; Yan L; Gu M; Jia X; Li M
Medicine (Baltimore); 2023 Feb; 102(6):e32872. PubMed ID: 36820582
[TBL] [Abstract] [Full Text] [Related]
[Next]
